| Dr Chidiebere Maquincy Ibekwe, MD, MPH, FACP | |
|
400 E 10th St, Anniston, AL 36207-4716 | |
| (256) 235-5639 | |
| Not Available |
| Full Name | Dr Chidiebere Maquincy Ibekwe |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 21 Years |
| Location | 400 E 10th St, Anniston, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093081531 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 35211 (Alabama) | Secondary |
| 207R00000X | Internal Medicine | 80194 (Georgia) | Secondary |
| 208M00000X | Hospitalist | 80194 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Alabama Medical Center | Florence, AL | Hospital |
| Wellstar Paulding Hospital | Hiram, GA | Hospital |
| Northeast Alabama Regional Medical Center | Anniston, AL | Hospital |
| Wellstar Douglas Hospital | Douglasville, GA | Hospital |
| University Of Alabama Hospital | Birmingham, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ecm Health Group Llc | 9436395225 | 87 |
| The Health Care Authority Of The City Of Anniston | 3971408923 | 24 |
| Wellstar Medical Group, Llc | 6709065402 | 1839 |
News Archive
The Knut and Alice Wallenberg Foundation will give a little over SEK 16 million to the development of new, highly-efficient mucosal vaccines. The vaccines will be drinkable or given as a nasal spray. Professor Nils Lycke at MIVAC at the Sahlgrenska Academy will in cooperation with researchers at Chalmers University of Technology and Lund University, combine technologies to develop the next generation of effective mucosal vaccines based on immunomodulation and cell-targeted nanoparticles.
Infinity Pharmaceuticals, Inc. today announced the initiation of the randomized Phase 2 portion of the trial of IPI-926 in combination with gemcitabine in patients with previously untreated, metastatic, pancreatic cancer.
Today's biggest health policy news surrounds an announcement by the White House that President Obama will install a new Medicare and Medicaid chief with a recess appointment the bypasses the confirmation process.
In children with autism, repetitive behaviors and gastrointestinal problems may be connected, new research has found.
John Wiley & Sons, Inc., announced today the launch of a new open access, interdisciplinary journal providing rapid publication of cutting-edge research across the broad field of immunology.
› Verified 9 days ago
| Entity Name | The Health Care Authority Of The City Of Anniston |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003996000 PECOS PAC ID: 3971408923 Enrollment ID: O20031203000272 |
News Archive
The Knut and Alice Wallenberg Foundation will give a little over SEK 16 million to the development of new, highly-efficient mucosal vaccines. The vaccines will be drinkable or given as a nasal spray. Professor Nils Lycke at MIVAC at the Sahlgrenska Academy will in cooperation with researchers at Chalmers University of Technology and Lund University, combine technologies to develop the next generation of effective mucosal vaccines based on immunomodulation and cell-targeted nanoparticles.
Infinity Pharmaceuticals, Inc. today announced the initiation of the randomized Phase 2 portion of the trial of IPI-926 in combination with gemcitabine in patients with previously untreated, metastatic, pancreatic cancer.
Today's biggest health policy news surrounds an announcement by the White House that President Obama will install a new Medicare and Medicaid chief with a recess appointment the bypasses the confirmation process.
In children with autism, repetitive behaviors and gastrointestinal problems may be connected, new research has found.
John Wiley & Sons, Inc., announced today the launch of a new open access, interdisciplinary journal providing rapid publication of cutting-edge research across the broad field of immunology.
› Verified 9 days ago
| Entity Name | Ecm Health Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346588852 PECOS PAC ID: 9436395225 Enrollment ID: O20130424000304 |
News Archive
The Knut and Alice Wallenberg Foundation will give a little over SEK 16 million to the development of new, highly-efficient mucosal vaccines. The vaccines will be drinkable or given as a nasal spray. Professor Nils Lycke at MIVAC at the Sahlgrenska Academy will in cooperation with researchers at Chalmers University of Technology and Lund University, combine technologies to develop the next generation of effective mucosal vaccines based on immunomodulation and cell-targeted nanoparticles.
Infinity Pharmaceuticals, Inc. today announced the initiation of the randomized Phase 2 portion of the trial of IPI-926 in combination with gemcitabine in patients with previously untreated, metastatic, pancreatic cancer.
Today's biggest health policy news surrounds an announcement by the White House that President Obama will install a new Medicare and Medicaid chief with a recess appointment the bypasses the confirmation process.
In children with autism, repetitive behaviors and gastrointestinal problems may be connected, new research has found.
John Wiley & Sons, Inc., announced today the launch of a new open access, interdisciplinary journal providing rapid publication of cutting-edge research across the broad field of immunology.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Chidiebere Maquincy Ibekwe, MD, MPH, FACP 8954 Hospital Dr, Douglasville, GA 30134-2272 Ph: (678) 838-2585 | Dr Chidiebere Maquincy Ibekwe, MD, MPH, FACP 400 E 10th St, Anniston, AL 36207-4716 Ph: (256) 235-5639 |
News Archive
The Knut and Alice Wallenberg Foundation will give a little over SEK 16 million to the development of new, highly-efficient mucosal vaccines. The vaccines will be drinkable or given as a nasal spray. Professor Nils Lycke at MIVAC at the Sahlgrenska Academy will in cooperation with researchers at Chalmers University of Technology and Lund University, combine technologies to develop the next generation of effective mucosal vaccines based on immunomodulation and cell-targeted nanoparticles.
Infinity Pharmaceuticals, Inc. today announced the initiation of the randomized Phase 2 portion of the trial of IPI-926 in combination with gemcitabine in patients with previously untreated, metastatic, pancreatic cancer.
Today's biggest health policy news surrounds an announcement by the White House that President Obama will install a new Medicare and Medicaid chief with a recess appointment the bypasses the confirmation process.
In children with autism, repetitive behaviors and gastrointestinal problems may be connected, new research has found.
John Wiley & Sons, Inc., announced today the launch of a new open access, interdisciplinary journal providing rapid publication of cutting-edge research across the broad field of immunology.
› Verified 9 days ago